BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3286046)

  • 1. Role of angiotensin in autoregulation of cerebral blood flow.
    Paulson OB; Waldemar G; Andersen AR; Barry DI; Pedersen EV; Schmidt JF; Vorstrup S
    Circulation; 1988 Jun; 77(6 Pt 2):I55-8. PubMed ID: 3286046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibition and autoregulation of cerebral blood flow in spontaneously hypertensive and normotensive rats.
    Strandgaard S; Barry DI; Paulson OB
    Scand J Urol Nephrol Suppl; 1984; 79():35-8. PubMed ID: 6089316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure.
    Paulson OB; Vorstrup S; Andersen AR; Smith J; Godtfredsen J
    J Hypertens Suppl; 1985 Dec; 3(3):S487-8. PubMed ID: 2856774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man.
    Waldemar G; Schmidt JF; Andersen AR; Vorstrup S; Ibsen H; Paulson OB
    J Hypertens; 1989 Mar; 7(3):229-35. PubMed ID: 2540235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulation of glomerular blood flow during converting-enzyme inhibition by captopril.
    Steinhausen M; Holz FG
    Biomed Biochim Acta; 1987; 46(12):1005-9. PubMed ID: 3330936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of captopril on cerebral blood flow in hypertensive rats before and after cerebral ischemia].
    Adzhienko LM
    Eksp Klin Farmakol; 1999; 62(5):18-20. PubMed ID: 10572745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation.
    Estrup TM; Paulson OB; Strandgaard S
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):188-92. PubMed ID: 11881121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of angiotensin II on the cerebral circulation and function].
    Nagao T
    Nihon Rinsho; 1999 May; 57(5):1096-102. PubMed ID: 10361441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitors and cerebral blood flow.
    Paulson OB; Waldemar G
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():69-72; discussion 72-3. PubMed ID: 2283657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension.
    Baumbach GL; Chillon JM
    J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular effects of the converting enzyme inhibitor captopril.
    Jarden JO; Barry DI; Strandgaard S; Graham DI; Paulson OB
    J Hypertens Suppl; 1983 Dec; 1(2):126-8. PubMed ID: 6400112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of captopril and enalapril on the cerebral circulation of normotensive rats].
    Adzhienko LM; Isaak AD
    Eksp Klin Farmakol; 1999; 62(3):18-9. PubMed ID: 10439941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.